Lab monkey prices at record highs as China’s biotech boom fuels windfall for breeders
Soaring demand for preclinical testing in China’s biotech industry has created an unexpected windfall for the laboratories that breed monkeys used in drug trials. Beijing-based Joinn Laboratories, a…
Read the full articleYou might also wanna read
China’s lab monkey prices hit Covid-era highs on new drug R&D demand
A boom in China’s new drug research and development is driving laboratory monkey prices back to coronavirus pandemic-era highs, forcing some
The value of Chinese Biotech
A handpicked article read aloud from the latest issue of The Economist

US biotechs turn secretive as they fear competition from rising Chinese industry
US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell End
China's biotech rise: A case study in multiple myeloma drug development
A drug for multiple myeloma should have been an early warning that China is racing ahead in biotech
Greater Bay Area emerges as launchpad for China's biotech rise
GUANGZHOU, July 3 (Xinhua) -- In the humid heat of July in southern China, the Akeso Greater Bay Area Technology Park in Zhongshan, Guangdon

China investiert neuerdings massiv in den Bereich Biotechnologie
China hat die Biotechnologie als Schlüsselbranche entdeckt. Der globale Konkurrenzdruck wächst. Es wäre nicht der erste Industriebereich, in

Comments
Sign in to join the conversation.
No comments yet. Be the first.